Analyst Ranking
Bottom 3%
#5350 out of 5510 analysts
Average Return
-5.03%
Win Rate
38%53 out of 138
Risk vs Reward
Poor
Good

David Turkaly's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Neuronetics IncSTIM
+366.27%$0.83$3.87
2024-08-14 -
2025-08-13
Buy
Haemonetics CorpHAE
+135.84%$40.09$94.55
2017-07-13 -
2018-07-13
Buy
Icad IncICAD
+99.77%$8.88$17.74
2020-02-05 -
2021-02-05
Buy
Axogen IncAXGN
+93.03%$22.68$43.78
2025-10-30 -
2026-09-14
Buy
Lantheus Holdings IncLNTH
+84.23%$54.86$101.07
2025-08-07 -
2026-08-06
Buy

David Turkaly's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Enovis CorpENOV
3Buy$47.00+157.96%Maintains
13 days ago
Stryker CorpSYK
5Buy$400.00+41.91%Maintains
a month ago
Axogen IncAXGN
9Buy$55.00+25.63%Maintains
2 months ago
Lantheus Holdings IncLNTH
13Buy$115.00+14.63%Reiterates
3 months ago
Mimedx Group IncMDXG
3Buy$6.00+29.31%Maintains
5 months ago
Zimmer Biomet Holdings IncZBH
12Buy$105.00+8.76%Maintains
5 months ago
Tela Bio IncTELA
8Buy$3.00+188.46%Maintains
6 months ago
Apyx Medical CorpAPYX
4Buy$8.00+164.90%Upgrades
10 months ago
Orthopediatrics CorpKIDS
12Buy$25.00+11.91%Maintains
a year ago
Orthofix Medical IncOFIX
2HoldN/AN/AReiterates
a year ago
Globus Medical IncGMED
3HoldN/AN/AReiterates
a year ago
Haemonetics CorpHAE
10Buy$100.00N/AReiterates
a year ago
Steris PLCSTE
15Buy$280.00N/AMaintains
a year ago
Integra Lifesciences Holdings CorpIART
14Buy$25.00N/AMaintains
a year ago
Crowdstrike Holdings IncCRWD
1Buy$125.00N/AMaintains
a year ago
Teleflex IncTFX
11HoldN/AN/AReiterates
a year ago
Si Bone IncSIBN
6Buy$32.00N/AReiterates
2 years ago
Snap IncSNAP
1Buy$16.00N/AReiterates
2 years ago
Nevro CorpNVRO
7HoldN/AN/AReiterates
2 years ago
Neuronetics IncSTIM
4Buy$3.00N/AMaintains
2 years ago
Paragon 28 IncFNA
4Buy$20.00N/AMaintains
2 years ago
Icad IncICAD
4Buy$4.00N/AMaintains
3 years ago
Cognyte Software LtdCGNT
1Buy$5.00N/AInitiates Coverage On
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.